Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Daprodustat 是一种口服具有活力的缺氧诱导因子脯氨酰羟化酶 (HIFPH) 抑制剂,可用于与慢性肾病相关的贫血病的研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 419 | 待询 | ||
5 mg | ¥ 755 | 待询 | ||
10 mg | ¥ 1,250 | 待询 | ||
25 mg | ¥ 2,060 | 待询 | ||
50 mg | ¥ 3,455 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 660 | 待询 |
产品描述 | Daprodustat (GSK1278863) is a HIF-prolyl hydroxylase inhibitor. |
体外活性 | GSK1278863 induces an effective EPO response and stimulates non-EPO mechanisms for erythropoiesis. [1] |
激酶实验 | SK Assay: A medium-throughput assay suitable for screening for inhibitors of recombinant human SK has been established. Briefly, 5 μg of purified GST-SK fusion protein are combined with 12 nM sphingosine, which contains a 100-fold dilution of [3-3H]sphingosine (20 Ci/mmol), 1 mM ATP, 1 mM magnesium chloride, and 200 μL of assay buffer [20 mM Tris HCl (pH 7.4), 20% glycerol, 1 mM beta-mercaptoethanol, 1 mM EDTA, 20 mM zinc chloride, 1 mM sodium orthovanadate, 15 mM sodium fluoride, and 0.5 mM 4-deoxypyridoxine]. Assays are run for 30 min at 25°C with shaking and contains either 1% DMSO or 5 g/mL test compound, which corresponds to concentrations of 10–25 μM. The reactions are terminated with 50 μL of concentrated ammonium hydroxide, followed by extraction of the assay mixture with chloroform:methanol (2:1). The aqueous portion is transferred to scintillation vials and radioactivity is quantified as a measure of [3H]]S1P formation using a Beckman LS 3801 Scintillation Counter. The intra-assay coefficient of variation is ~10%, whereas interassay variation is ~20%. |
别名 | GSK1278863 |
分子量 | 393.43 |
分子式 | C19H27N3O6 |
CAS No. | 960539-70-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: <1 mg/mL
H2O: <1 mg/mL
DMSO: 10 mg/mL (25.42 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5417 mL | 12.7087 mL | 25.4175 mL | 63.5437 mL |
5 mM | 0.5083 mL | 2.5417 mL | 5.0835 mL | 12.7087 mL | |
10 mM | 0.2542 mL | 1.2709 mL | 2.5417 mL | 6.3544 mL | |
20 mM | 0.1271 mL | 0.6354 mL | 1.2709 mL | 3.1772 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Daprodustat 960539-70-2 Angiogenesis Chromatin/Epigenetic Metabolism HIF/HIF Prolyl-Hydroxylase HIF GSK-1278863 HIF-PH Inhibitor Hypoxia-inducible factors inhibit GSK 1278863 GSK1278863 HIFs inhibitor